Modulation of sialyl-glycoconjugate secretion in cultures of immortalized lymphocytes by treatment with substance P and interleukin-2.
Kage
A
A
Institut für Klinische Chemie und Biochemie, Universitätsklinikum Rudolf Virchow, Berlin, Federal Republic of Germany.
Siebert
U
U
Rogowski
S
S
Köttgen
E
E
D000371:Agglutination; D002240:Carbohydrate Sequence; D002461:Cell Line, Transformed; D004187:Disaccharides / Q000378:metabolism*; D006023:Glycoproteins / Q000096:biosynthesis; D006031:Glycosylation; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D037102:Lectins; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D008969:Molecular Sequence Data; D037121:Plant Lectins; D011994:Recombinant Proteins / Q000494:pharmacology; D054788:Ribosome Inactivating Proteins; D013373:Substance P / Q000494:pharmacology*
D004187:Disaccharides; D006023:Glycoproteins; D007376:Interleukin-2; D037102:Lectins; D037121:Plant Lectins; D011994:Recombinant Proteins; C050600:Sambucus nigra lectins; D013373:Substance P; C063866:N-acetylneuraminyl-(2-6)-galactose; D054788:Ribosome Inactivating Proteins